Brazil acts to spur domestic production of key medicines

Brazil announced a major initiative Thursday to spur domestic production of medicines and equipment to combat diseases such as Alzheimers.

Alexandre Padilha said the plans call for major government investments in the field, public-private partnerships to produce drugs, and fast-tracking patents and registration of products crucial to .

He estimated that the measures would lead to savings of 354 million reais ($179 million) over five years, because the government currently imports most of the medicines involved and makes them available to the national health system.

"To produce here in Brazil means a saving for the government and the consumer," the Padilha said. "These products can lead to price reductions for the consumer."

He made the announcement at a meeting hosted by the Federation of Industries of the State of Sao Paolo.

He said the would extend seven billion reais ($3.5 billion) in credits to Brazilian firms involved in innovative health projects and pump another 1.3 billion reais ($651 million) into the infrastructure of public laboratories.

He said key regulatory bodies—the National Health Surveillance Agency ANVISA, the National Institute of Intellectual Property (INPI) and the Brazilian Association of Technical Norms (ABNT)—would sign agreements aimed at speeding up the process for obtaining patents and registering products.

add to favorites email to friend print save as pdf

Related Stories

Brazil moves to combat 'crack epidemic'

Dec 07, 2011

The Brazilian government on Wednesday launched a war on what it called a "crack epidemic", including medical treatment for addicts and a crackdown on trafficking, particularly in border areas.

Recommended for you

Drug research and development more efficient than expected

Feb 27, 2015

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Use new meningitis vaccines only for outbreaks

Feb 26, 2015

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

Feb 26, 2015

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

Tagging drugs to fight counterfeit medicines

Feb 25, 2015

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.